These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15780613)

  • 21. 5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors.
    Morley AD; Kenny PW; Burton B; Heald RA; Macfaul PA; Mullett J; Page K; Porres SS; Ribeiro LR; Smith P; Ward S; Wilkinson TJ
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1658-61. PubMed ID: 19231183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.
    Robichaud J; Bayly CI; Black WC; Desmarais S; Léger S; Massé F; McKay DJ; Oballa RM; Pâquet J; Percival MD; Truchon JF; Wesolowski G; Crane SN
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3146-51. PubMed ID: 17408953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
    Rankovic Z; Cai J; Kerr J; Fradera X; Robinson J; Mistry A; Hamilton E; McGarry G; Andrews F; Caulfield W; Cumming I; Dempster M; Waller J; Scullion P; Martin I; Mitchell A; Long C; Baugh M; Westwood P; Kinghorn E; Bruin J; Hamilton W; Uitdehaag J; van Zeeland M; Potin D; Saniere L; Fouquet A; Chevallier F; Deronzier H; Dorleans C; Nicolai E
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1524-7. PubMed ID: 20149657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
    Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
    J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.
    Katunuma N; Matsui A; Inubushi T; Murata E; Kakegawa H; Ohba Y; Turk D; Turk V; Tada Y; Asao T
    Biochem Biophys Res Commun; 2000 Jan; 267(3):850-4. PubMed ID: 10673380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors.
    Cai J; Robinson J; Belshaw S; Everett K; Fradera X; van Zeeland M; van Berkom L; van Rijnsbergen P; Popplestone L; Baugh M; Dempster M; Bruin J; Hamilton W; Kinghorn E; Westwood P; Kerr J; Rankovic Z; Arbuckle W; Bennett DJ; Jones PS; Long C; Martin I; Uitdehaag JC; Meulemans T
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6890-4. PubMed ID: 21030256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors.
    Irie O; Yokokawa F; Ehara T; Iwasaki A; Iwaki Y; Hitomi Y; Konishi K; Kishida M; Toyao A; Masuya K; Gunji H; Sakaki J; Iwasaki G; Hirao H; Kanazawa T; Tanabe K; Kosaka T; Hart TW; Hallett A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4642-6. PubMed ID: 18662880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
    Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
    J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene and cis-6-oxo-hexahydropyrrolo[3,2-c]pyrazole based scaffolds: design rationale, synthesis and cysteinyl proteinase inhibition.
    Wang Y; Benn A; Flinn N; Monk T; Ramjee M; Watts J; Quibell M
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1327-31. PubMed ID: 15713380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
    Zhou NE; Guo D; Thomas G; Reddy AV; Kaleta J; Purisima E; Menard R; Micetich RG; Singh R
    Bioorg Med Chem Lett; 2003 Jan; 13(1):139-41. PubMed ID: 12467634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
    Tavares FX; Deaton DN; Miller AB; Miller LR; Wright LL; Zhou HQ
    J Med Chem; 2004 Oct; 47(21):5049-56. PubMed ID: 15456248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel scaffold for cathepsin K inhibitors.
    Teno N; Miyake T; Ehara T; Irie O; Sakaki J; Ohmori O; Gunji H; Matsuura N; Masuya K; Hitomi Y; Nonomura K; Horiuchi M; Gohda K; Iwasaki A; Umemura I; Tada S; Kometani M; Iwasaki G; Cowan-Jacob SW; Missbach M; Lattmann R; Betschart C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6096-100. PubMed ID: 17911019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin K and the design of inhibitors of cathepsin K.
    Yamashita DS; Dodds RA
    Curr Pharm Des; 2000 Jan; 6(1):1-24. PubMed ID: 10637370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors.
    Yamashita DS; Marquis RW; Xie R; Nidamarthy SD; Oh HJ; Jeong JU; Erhard KF; Ward KW; Roethke TJ; Smith BR; Cheng HY; Geng X; Lin F; Offen PH; Wang B; Nevins N; Head MS; Haltiwanger RC; Narducci Sarjeant AA; Liable-Sands LM; Zhao B; Smith WW; Janson CA; Gao E; Tomaszek T; McQueney M; James IE; Gress CJ; Zembryki DL; Lark MW; Veber DF
    J Med Chem; 2006 Mar; 49(5):1597-612. PubMed ID: 16509577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.
    Hilpert H; Mauser H; Humm R; Anselm L; Kuehne H; Hartmann G; Gruener S; Banner DW; Benz J; Gsell B; Kuglstatter A; Stihle M; Thoma R; Sanchez RA; Iding H; Wirz B; Haap W
    J Med Chem; 2013 Dec; 56(23):9789-801. PubMed ID: 24224654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.